Briony Larance1, Gabrielle Campbell2, Amy Peacock3, Suzanne Nielsen4, Raimondo Bruno3, Wayne Hall5, Nicholas Lintzeris6, Milton Cohen7, Louisa Degenhardt2. 1. National Drug and Alcohol Research Centre, UNSW Australia, Sydney, New South Wales, Australia. Electronic address: b.larance@unsw.edu.au. 2. National Drug and Alcohol Research Centre, UNSW Australia, Sydney, New South Wales, Australia. 3. School of Medicine (Psychology), University of Tasmania, Hobart, Tasmania, Australia. 4. National Drug and Alcohol Research Centre, UNSW Australia, Sydney, New South Wales, Australia; Drug and Alcohol Services, South East Sydney Local Health District (SESLHD), New South Wales, Australia. 5. School of Population Health, University of Queensland, Queensland, Australia. 6. Drug and Alcohol Services, South East Sydney Local Health District (SESLHD), New South Wales, Australia; University of Sydney, Addiction Medicine, Central Clinical School, Camperdown, New South Wales, Australia. 7. St. Vincent's Clinical School, UNSW Australia, Sydney, New South Wales, Australia.
Abstract
BACKGROUND: The utilisation of pharmaceutical opioids has increased internationally, and there is evidence of increasing risky alcohol consumption with ageing. This study examines the patterns and correlates of risky drinking among people with chronic non-cancer pain (CNCP) prescribed opioids, and the associations between alcohol consumption and pain. METHODS: The Pain and Opioids IN Treatment cohort comprises 1514 people in Australia prescribed pharmaceutical opioids for CNCP. Participants reported lifetime, past year and past month alcohol use, as well as mental and physical health, other substance use, pain characteristics, and current opioid dose. RESULTS: Less than one-tenth of the sample were 'lifetime abstainers' (7%); 34% were 'former drinkers'; 34% were 'non-risky drinkers' (i.e., past 12 month use ≤4 standard drinks); 16% were 'occasional risky drinkers'; and 8% were 'regular risky drinkers' (i.e., ≥weekly use of >4 standard drinks). Males reported greater levels of alcohol use, and a third (33%) of the total sample reported a lifetime alcohol use disorder. Controlling for demographics, mental health, physical health and substance use disorder history, 'former drinkers' (cf. 'non-risky drinkers') reported higher pain severity and interference ratings, and lower pain coping. 'Occasional risky drinkers' and 'regular risky drinkers' (cf. 'non-risky drinkers') reported higher levels of pain interference. CONCLUSIONS: Among people with CNCP, those who abstained from alcohol or drank at risky levels reported poorer pain outcomes compared with moderate drinkers. Early identification and intervention for risky drinking among people is critical, particularly given the risks associated with co-administration of alcohol and opioids.
BACKGROUND: The utilisation of pharmaceutical opioids has increased internationally, and there is evidence of increasing risky alcohol consumption with ageing. This study examines the patterns and correlates of risky drinking among people with chronic non-cancer pain (CNCP) prescribed opioids, and the associations between alcohol consumption and pain. METHODS: The Pain and Opioids IN Treatment cohort comprises 1514 people in Australia prescribed pharmaceutical opioids for CNCP. Participants reported lifetime, past year and past month alcohol use, as well as mental and physical health, other substance use, pain characteristics, and current opioid dose. RESULTS: Less than one-tenth of the sample were 'lifetime abstainers' (7%); 34% were 'former drinkers'; 34% were 'non-risky drinkers' (i.e., past 12 month use ≤4 standard drinks); 16% were 'occasional risky drinkers'; and 8% were 'regular risky drinkers' (i.e., ≥weekly use of >4 standard drinks). Males reported greater levels of alcohol use, and a third (33%) of the total sample reported a lifetime alcohol use disorder. Controlling for demographics, mental health, physical health and substance use disorder history, 'former drinkers' (cf. 'non-risky drinkers') reported higher pain severity and interference ratings, and lower pain coping. 'Occasional risky drinkers' and 'regular risky drinkers' (cf. 'non-risky drinkers') reported higher levels of pain interference. CONCLUSIONS: Among people with CNCP, those who abstained from alcohol or drank at risky levels reported poorer pain outcomes compared with moderate drinkers. Early identification and intervention for risky drinking among people is critical, particularly given the risks associated with co-administration of alcohol and opioids.
Authors: Angela Christina Busch; Meenakshi Denduluri; Joseph Glass; Scott Hetzel; Shalu P Gugnani; Michele Gassman; Dean Krahn; Brienna Deyo; Randall Brown Journal: Alcohol Clin Exp Res Date: 2017-06-12 Impact factor: 3.455
Authors: Marlene C Lira; Judith I Tsui; Jane M Liebschutz; Jonathan Colasanti; Christin Root; Debbie M Cheng; Alexander Y Walley; Meg Sullivan; Christopher Shanahan; Kristen O'Connor; Catherine Abrams; Leah S Forman; Christine Chaisson; Carly Bridden; Melissa C Podolsky; Kishna Outlaw; Catherine E Harris; Wendy S Armstrong; Carlos Del Rio; Jeffrey H Samet Journal: HIV Res Clin Pract Date: 2019-04
Authors: Gerald Cochran; Elizabeth Charron; Jennifer L Brown; Alina Cernasev; Kenneth C Hohmeier; T John Winhusen Journal: Drug Alcohol Depend Date: 2022-03-16 Impact factor: 4.852
Authors: Joanne Salas; Jeffrey F Scherrer; Frank David Schneider; Mark D Sullivan; Kathleen K Bucholz; Thomas Burroughs; Laurel A Copeland; Brian K Ahmedani; Patrick J Lustman Journal: Pain Date: 2017-02 Impact factor: 7.926